BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) represent an increasing health burden and morbidity in Canada. Viral hepatitis, specifically HCV, has high prevalence among persons born between 1945 and 1965, with 45% to 85% of infected adults asymptomatic and unaware of their infection. Screening has been shown to be cost effective in the detection and treatment of viral hepatitis. OBJECTIVE: To quantify incidence and identify undocumented HBV and HCV infection in hospitalized patients at a single centre with secondary analysis of risk factors as part of a quality improvement initiative. METHODS: A one-time antibody test was conducted in patients admitted to the acute medicine and gastroenterology services. RESULTS: Over a 12-week period, hospital screening for HBV and HCV was performed in 37.3% of 995 admitted patients. There was identification of 15 previously undiagnosed cases of HCV (4%) and 36 undocumented cases of occult (ie, antihepatitis B core antigen seropositive) or active (ie, hepatitis B surface antigen seropositive) HBV (9.7%). Among patients with positive screens, 60% of seropositive HCV patients had no identifiable risk factors. CONCLUSIONS: The prevalence of HBV and HCV infection among hospitalized patients in Vancouver was higher than that of the general population. Risk factors for contraction are often not identified. These results can be used as part of an ongoing discussion regarding a 'seek and treat' approach to the detection and treatment of chronic blood-borne viral illnesses.
BACKGROUND:Hepatitis B virus (HBV) and hepatitis C virus (HCV) represent an increasing health burden and morbidity in Canada. Viral hepatitis, specifically HCV, has high prevalence among persons born between 1945 and 1965, with 45% to 85% of infected adults asymptomatic and unaware of their infection. Screening has been shown to be cost effective in the detection and treatment of viral hepatitis. OBJECTIVE: To quantify incidence and identify undocumented HBV and HCV infection in hospitalized patients at a single centre with secondary analysis of risk factors as part of a quality improvement initiative. METHODS: A one-time antibody test was conducted in patients admitted to the acute medicine and gastroenterology services. RESULTS: Over a 12-week period, hospital screening for HBV and HCV was performed in 37.3% of 995 admitted patients. There was identification of 15 previously undiagnosed cases of HCV (4%) and 36 undocumented cases of occult (ie, antihepatitis B core antigen seropositive) or active (ie, hepatitis B surface antigen seropositive) HBV (9.7%). Among patients with positive screens, 60% of seropositive HCVpatients had no identifiable risk factors. CONCLUSIONS: The prevalence of HBV and HCV infection among hospitalized patients in Vancouver was higher than that of the general population. Risk factors for contraction are often not identified. These results can be used as part of an ongoing discussion regarding a 'seek and treat' approach to the detection and treatment of chronic blood-borne viral illnesses.
Authors: David B Rein; John S Wittenborn; Cindy M Weinbaum; Miriam Sabin; Bryce D Smith; Sarah B Lesesne Journal: Dig Liver Dis Date: 2010-06-17 Impact factor: 4.088
Authors: Justin Cheung; Tim K Lee; Chong-Ze Teh; Caroline Y M Wang; W C Peter Kwan; Eric M Yoshida Journal: Can J Gastroenterol Date: 2005-04 Impact factor: 3.522
Authors: Jonathan Shepherd; Håkan F T Brodin; Carolyn Backer Cave; Norman R Waugh; Alison Price; John Gabbay Journal: Int J Technol Assess Health Care Date: 2005 Impact factor: 2.188
Authors: J B Kallman; A Arsalla; V Park; S Dhungel; P Bhatia; D Haddad; A Wheeler; Z M Younossi Journal: Aliment Pharmacol Ther Date: 2009-05-01 Impact factor: 8.171
Authors: Kate Shannon; Thomas Kerr; Brandon Marshall; Kathy Li; Ruth Zhang; Steffanie A Strathdee; Mark W Tyndall; Julio G S Montaner; Evan Wood Journal: Arch Pediatr Adolesc Med Date: 2010-01
Authors: Stephen Ip; Jo-Ann Ford; Kirby Lau; Vladimir Marquez; Marisa Guan; Carolyn Klassen; Jessica Chan; Wc Peter Kwan; Mel Krajden; Eric M Yoshida Journal: Can J Infect Dis Med Microbiol Date: 2015 Jul-Aug Impact factor: 2.471